Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Drug Screening Identifies Niclosamide as an Inhibitor of Breast Cancer Stem-Like Cells

18 Sept 2013

Abstract excerpt

The primary cause of death from breast cancer is the progressive growth of tumors and resistance to conventional therapies. It is currently believed that recurrent cancer is repopulated according to a recently proposed cancer stem cell hypothesis. New therapeutic strategies that specifically target cancer stem-like cells may represent a new avenue of cancer therapy. We aimed to discover novel compounds that...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Epigenetics and DNA Methylation
Share to FOXO transcription factor regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24058587
DOI: 10.1371/journal.pone.0074538

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Drug Screening Identifies Niclosamide as an Inhibitor of Breast Cancer Stem-Like CellsPMID 24058587Read ↗

Selectively Targeting Breast Cancer Stem Cells By 8-Quinolinol and NiclosamideSemantic proximity Read ↗

Identification of a selective small molecule inhibitor of breast cancer stem cellsSemantic proximity Read ↗

Silibinin exhibits anti-tumor effects in a breast cancer stem cell model by targeting stemness and induction of differentiation and apoptosisSemantic proximity Read ↗

Ovarian cancer stem cell-specific gene expression profiling and targeted drug prescreeningSemantic proximity Read ↗

Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput ScreeningSemantic proximity Read ↗

Phenotypic High-Throughput Screening Elucidates Target Pathway in Breast Cancer Stem Cell–Like CellsSemantic proximity Read ↗

Phenotypic screening reveals topoisomerase I as a breast cancer stem cell therapeutic target.Semantic proximity Read ↗

Ivermectin as an inhibitor of cancer stem‑like cellsSemantic proximity Read ↗

A novel molecular marker of breast cancer stem cells identified by cell-SELEX method.Semantic proximity Read ↗

A mammosphere formation RNAi screen reveals that ATG4A promotes a breast cancer stem-like phenotype.Semantic proximity Read ↗

Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsivenessSemantic proximity Read ↗

Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.